| 发明名称 |
A STABLE PHARMACEUTICAL FORMULATION COMPRISING TORSEMIDE MODIFICATION II. |
| 摘要 |
<p>Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.</p> |
| 申请公布号 |
MXPA04007695(A) |
申请公布日期 |
2004.12.07 |
| 申请号 |
MX2004PA07695 |
申请日期 |
2003.02.07 |
| 申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
MARKO KORDOVA |
| 分类号 |
A01N43/40;A61K9/00;A61K9/16;A61K9/20;A61K31/44;A61K31/4409;A61K47/12;A61K47/26;A61K47/32;A61K47/38;A61P9/00;A61P9/12;C07D213/70;C07D213/74;(IPC1-7):A61K9/00 |
主分类号 |
A01N43/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
